Helius Therapeutics
Manufacturing · New Zealand · 11-50 Employees
View Company Info for Free
Overview
Headquarters
18 Ron Driver East Tamaki Poland, Auckla...Phone Number
+64 99734099Website
www.helius.co.nzRevenue
$9.1 MillionIndustry
About Helius Therapeutics
Helius Therapeutics Org Chart
Is Helius Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Helius Therapeutics has new funding data
Helius Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Helius Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Helius Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Helius Therapeutics
Check if Helius Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Helius Therapeutics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Helius Therapeutics is spiking on competitors!
Recommended Actions
Find VP level buyers at Helius Therapeutics
Find 3 more new buyers
Company Profile Activity
Activity Insights
Helius Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Helius Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Helius Therapeutics.
Helius Therapeutics Tech Stack
A closer look at the technologies used by Helius Therapeutics
Helius Therapeutics News & Media
Chief Commercial Officer At Helius Announced
Mark Morrison has been appointed Chief Commercial Officer (CCO) at Helius Therapeutics - New Zealand’s largest licenced medicinal cannabis company. Mark Morrison For six months ...Helius Appoints Chief Operating Officer
Mary Alice Simon has been appointed Chief Operating Officer (COO) at Helius Therapeutics - New Zealand’s largest licenced medicinal cannabis company. Ms Simon joins Helius with extensive experience in the pharmaceuticals industry - both in Operations and ...MediPharm Labs Australia Signs First International White-Label Supply Deal with New Zealand based Helius Therapeutics
BARRIE, Ontario, April 24, 2020 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that its subsidiary, MediPharm Labs Australia Pty Ltd (“MediPharm Labs Australia”), has entered into an agreement to supply pharmaceutical-quality (GMP certified), white-label, cannabis oil products tNew Zealand cannabis firm Helius raises NZ$20M for expansion, clinical trials
Weeks before New Zealand’s medical marijuana regulations take effect, Auckland-based Helius Therapeutics says it has raised 20 million New Zealand dollars ($12.8 million) to help fund facility expansion and clinical trials. Helius is among nearly two-dozen companies that are licensed to grow cannabis for research purposes. After the regulatory foundation for New Zealand's medical cannabis sector enters into force April 1, Helius will transition from a solely research-based company to a verticall
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Helius Therapeutics
Helius Therapeutics has a bold vision, to become a world leader in the research, development and production of next-generation cannabinoid medicines. Our team is innovating to create the world’s safest and most efficacious cannabis-based medicines... Read More